12
Views
4
CrossRef citations to date
0
Altmetric
Original Articles

Advances in liver transplantation

New strategies and current care expand access, enhance survival

, MD, , MD, , MD & , MD
Pages 73-85 | Published online: 30 Jun 2015

References

  • Starzl TE, Marchioro TL, VonKaulla KN, et al. Homotransplantation of the liver in humans. Surg Gynecol Obstet 1963; 117: 659–76
  • Seaberg EC, Belle SH, Beringer KC, et al. Liver transplantation in the United States from 1987–1998: updated results from the Pitt-UNOS liver transplant registry. In: Cecka JM, Terasaki PI, eds. Clinical transplants 1998. Vol 14. Los Angeles: UCLA Tissue Typing Laboratory, 1999: 17–37
  • US Scientific Registry. Richmond, Va: United Network for Organ Sharing (UNOS), 1999. Available at: http://www.unos.org. Accessed Feb 19, 2004
  • Bruix J. Treatment of hepatocellular carcinoma. Hepatology 1997; 25(2): 259–62
  • Mazzaferro V, Regalia E, Doci R, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 1996; 334(11): 693–9
  • O'Grady JG, Alexander GJ, Hayllar KM, et al. Early indicators of prognosis in fulminant hepatic failure. Gastroenterology 1989; 97(2): 439–45
  • Fattovich G, Giustina G, Degos F, et al. Morbidity and mortality in compensated cirrhosis type C: a retrospective follow-up study of 384 patients. Gastroenterology 1997; 112(2): 651–5
  • Marino IR, Morelli F, Doria C, et al. Preoperative assessment of risk in liver transplantation: a multivariate analysis in 2376 cases of the UW era. Transplant Proc 1997; 29(1–2): 454–5
  • Lucey MR, Brown KA, Everson GT, et al. Minimal criteria for placement of adults on the liver transplant waiting list: a report of a national conference organized by the American Society of Transplant Physicians and the American Association for the Study of Liver Diseases. Liver Transpl Surg 1997; 3(6): 628–37
  • Watson CJ, Friend PJ, Jamieson NV, et al. Sirolimus: a potent new immunosuppressant for liver transplantation. Transplantation 1999; 67(4): 505–9
  • Trotter JF. Sirolimus in liver transplantation. Transplant Proc 2003; 35(3 Suppl): 193–200S
  • US Department of Health and Human Services. Guide to clinical preventive services: report of the US Preventive Services Task Force. 2nd ed. Baltimore: Williams & Wilkins, 1996
  • Textor SC, Canzanello VJ, Taler SJ, et al. Hypertension after transplantation. Liver Transpl Surg 1995; 1(5 Suppl 1): 20–8
  • Todo S, Demetris AJ, Van Thiel D, et al. Orthotopic liver transplantation for patients with hepatitis B virus-related liver disease. Hepatology 1991; 13(4): 619–26
  • Markowitz JS, Martin P, Conrad A J, et al. Prophylaxis against hepatitis B recurrence following liver transplantation using combination lamivudine and hepatitis B immune globulin. Hepatology 1998; 28(2): 585–9
  • Fukumoto T, Berg T, Ku Y, et al. Viral dynamics of hepatitis C early after orthotopic liver transplantation: evidence for rapid turnover of serum virions. Hepatology 1996; 24(6): 1351–4
  • Forman LM, Lewis JD, Berlin J A, et al. The association between hepatitis C infection and survival after orthotopic liver transplantation. Gastroenterology 2002; 122(4): 889–96
  • Gane EJ, Portmann BC, Naoumov NV, et al. Long-term outcome of hepatitis C infection after liver transplantation. N Engl J Med 1996; 334(13): 815–20
  • Marsh JW, Dvorchik I, Subotin M, et al. The prediction of risk of recurrence and time to recurrence of hepatocellular carcinoma after orthotopic liver transplantation: a pilot study. Hepatology 1997; 26(2): 444–50
  • De Vreede I, Steers JL, Burch PA, et al. Prolonged disease-free survival after orthotopic liver transplantation plus adjuvant chemoirradiation for cholangiocarcinoma. Liver Transpl 2000; 6(3): 309–16
  • Graziadei IW, Wiesner RH, Batts KP, et al. Recurrence of primary sclerosing cholangitis following liver transplantation. Hepatology 1999; 29(4): 1050–6
  • Hubscher SG, Elias E, Buckets JA, et al. Primary biliary cirrhosis: histological evidence of disease recurrence after liver transplantation. J Hepatol 1993; 18(2): 173–84
  • Milkiewicz P, Hubscher SG, Skiba G, et al. Recurrence of autoimmune hepatitis after liver transplantation. Transplantation 1999; 68(2): 253–6
  • Tran T, Changsri C, Peterson A, et al. Living donor liver transplantation: significant histologic abnormalities found on donor candidate biopsies. (Abstr) Gastroenterology 2003; 124(4 Suppl 1): A17
  • Trotter JF, Wachs M, Trouillot T, et al. Evaluation of 100 patients for living donor liver transplantation. Liver Transpl 2000; 6(3): 290–5
  • Bucuvalas JC, Ryckman FC. The long- and short-term outcome of living-donor liver transplantation. J Pediatr 1999; 134(3): 259–61

References

  • Kamath PS, Wiesner RH, Malinchoe M et al. A model to predict survival in patients with endstage liver disease.. Hepatology 2001; 33(2): 473–5
  • Freeman RB, Wiesner RH, Edwards E, et al. Results of the first year of the new liver allocation plan. Liver Transpl 2004; 10(1): 7–15

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.